Recorded Chinese product: 冠心宁注射液冠心宁注射液

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

丹参是一种在国家药监局注册认定的药品。该药品含有丹参、川芎-a1418f24等成分。

该药品关联的活性成分包括:丹参salvia、川芎Chuan Qiong。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:朗致集团万荣药业有限公司Chinese legal name: 朗致集团万荣药业有限公司。

您可以探索含有相同成分的其他药品:丹参-d5a58f0e成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 冠心宁注射液) is a medicine registered with the national drug regulatory authority. It contains salvia and other recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 丹参salvia, 川芎Chuan Qiong.

Manufacturers recorded for this product: 朗致集团万荣药业有限公司Chinese legal name: 朗致集团万荣药业有限公司.

Explore other medicines containing the same ingredient: 丹参 productssalvia products.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 冠心宁注射液Recorded Chinese product: 冠心宁注射液
  • 剂型Dosage form: 注射剂Injection
  • 规格Specification: 每支10mlRecorded Chinese specification: 每支10ml

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 朗致集团万荣药业有限公司Chinese legal name: 朗致集团万荣药业有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字Z14020181

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字Z14020181

Manufacturer

Chinese legal name: 朗致集团万荣药业有限公司 (domestically manufactured)

Traditional functions

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字Z14020181

生产企业

朗致集团万荣药业有限公司(国产)

功能主治

活血化瘀,通脉养心。用于冠心病心绞痛。

用法用量

1.肌内注射,一次2ml,一日1-2次。|2.静脉滴注,一次10-20ml,用5%葡萄糖注射液500ml稀释后使用,一日1次。

不良反应

头晕,寒颤,烦躁,出汗等不适症状。

禁忌

1.对本品及其成分过敏者禁用。 |2.有出血倾向者禁用。

注意事项

1.过敏体质者慎用。|2.孕妇慎用。|3.本品严禁静脉推注使用。|4. 本品不能与其他药混合滴注。|5. 静脉滴注时应小心,防止渗漏血管外而引起刺激疼痛;冬季可用30℃温水预热,以免除物理性刺激。|6.使用本品应采用一次性输液器(带终端滤器)。|7.用药期间饮食宜清淡,忌食生冷、油腻、辛辣难消化的食品,以免加重病情。|8.用药期间不要饮酒,吸烟,少喝浓茶或咖啡。|9.多吃水果及富含纤维食物,保持大便通畅。|1.0用药期间,注意休息,避免劳累,保证充足的睡眠。|11.保持心情舒畅,忌过度思虑,避免恼怒、抑郁等不良情绪。|12.从事适当的体育锻炼或体力活动,增强体质。

规格

每支10ml

证据Evidence

  • 批准文号: 国药准字Z14020181
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.